Group A and Group C Meningococcal Conjugate Vaccine (CRM197) Menphecia®

More Serogroup: Men ACWY
Long lasting: immunization memory, High affinity IgG, Mucosal immunity.
Strong Evidence: A 10-year evidence of MenACWY CRM Menhycia® evidence.
Saftey: A 10-year evidence of Men ACWY CRM Menhycia® evidence Safety of CRM 197

...

The third-generation technology

Produce humoral and cellular immunity

Stably stored and transported at 2–8°C

WHO Granted Emergency Use Listing (EUL) For Convidecia®

Approved in over 10 countries

The world's first inhaled COVID-19 vaccine Convidecia Air® has been approved as a booster dose in China, Morocco, and Indonesia. 

Induces humoral, cellular, and mucosal immunity

Needle-free vaccination

Asia's first and World's third Ebola virus disease vaccine

The only one approved for emergency use and national stockpile in China